Nirmal Das

Title: Nirmal Das - Innovator in Non-Alcoholic Fatty Liver Disease Treatment

Introduction

Nirmal Das is a prominent inventor based in Kolkata, India. He has made significant contributions to the field of medical research, particularly in the treatment of non-alcoholic fatty liver disease (NAFLD). His innovative work focuses on the development of compounds that can provide physiologically beneficial responses through the modulation of specific enzymes.

Latest Patents

Nirmal Das holds a patent for "Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof." This patent describes compounds that inhibit or modulate the Ubiquitin Ligase COP1 enzyme, which is crucial for treating diseases like NAFLD. The compounds are designed to increase the level of adipose triglyceride lipase (ATGL), thereby offering a new therapeutic approach to managing this condition.

Career Highlights

Nirmal Das is associated with the Council of Scientific and Industrial Research, where he has been instrumental in advancing research in his field. His dedication to innovation and scientific inquiry has led to the development of effective treatments that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Saheli Chowdhury and Subrata Das. Their collaborative efforts have contributed to the success of various research projects and innovations in the medical field.

Conclusion

Nirmal Das is a key figure in the fight against non-alcoholic fatty liver disease, with his patented compounds offering hope for effective treatment options. His work exemplifies the impact of innovation in medical research and the importance of collaboration in achieving scientific advancements.